SecBot SecBot

Protect Patient Access to Pharmacies Act

S. 2052 Sen. Jon Tester (D-MT) In committee
  1. Introduced Jun 20
  2. Committee Jun 20
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 20, 2023Next: Senate vote
1226d ago Jun 20, 2023: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 3 filings
Member trades
5trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Consumer & Retail 1Financials 1
Search all 2 companies, their asks and price moves Subscribe

Summary

Protect Patient Access to Pharmacies Act

Full summary2 paragraphs

This bill establishes certain requirements with respect to payments to pharmacies by prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit and Medicare Advantage.

Specifically, the Centers for Medicare & Medicaid Services (CMS) must ensure that payments sufficiently cover a pharmacy's costs to acquire and dispense covered drugs so as to enable the pharmacy to participate as a network provider. The CMS must (1) use relevant data from pharmacies with respect to acquisition and dispensing costs for covered drugs, (2) establish payment parameters, and (3) establish an appeal process for pharmacies about payments. The CMS must also evaluate the performance measures used by PDP sponsors for pharmacy price concessions or other performance fees and develop standardized performance measures.

Library of Congress summary, Jun 20, 2023

Summary versions
  • Introduced in SenateJun 20, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.